|
|
| 16.10 Real-Time Quote |  +0.36 / +2.29%Today’s Change | 8.40 Today|||52-Week Range 16.92 | -- Year-to-Date |
| Previous close | 15.74 |
| Today’s open | 15.84 |
| Day’s range | 14.57 - 16.92 |
| Volume | 119,700 |
| Average volume (3 months) | -- |
| Market cap | $292.8M |
| Dividend yield | -- |
| Earnings growth (last year) | -- |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +300.04% |
| P/E ratio | -- |
| Price/Sales | -- |
| Price/Book | 13.26 |
| Today’s change | Today’s % change | |
|---|---|---|
| THLDThreshold Pharmaceut... | -0.08 | -1.58% |
| ADHDAlcobra Ltd | +0.30 | +1.33% |
| CCXIChemoCentryx Inc | -0.19 | -2.67% |
| ATHXAthersys Inc | -0.02 | -0.55% |
| Next reporting date | May 28, 2014 |
| EPS forecast (this quarter) | -$0.32 |
| Annual revenue (last year) | $15.3M |
| Annual profit (last year) | $3.7M |
| Net profit margin | 23.96% |
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Rachel K. King |
Chief Financial Officer & Head-Media Relations Brian M. Hahn |
Corporate headquarters Gaithersburg, Maryland |
.
